Management of mild asthma has been for a long time unsatisfactory and not tested in clinical trials. The use (overuse) of SABA in patients "treated as" mild asthmatics has become of concern, and the association with severe adverse events has become clear. Adherence to regular ICS treatment is a major issue in this population. The rationale and efficacy of the “as needed ICS” will be discussed in this session.

• Review concerns associated with the use of rescue SABA in the absence of maintenance treatment.

• Discuss merits of as-needed ICS treatment strategies in mild asthma.